Switzerland fast-tracks anti-viral medication against COVID-19

2 July 2020 - Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval ...

Read more →

Swissmedic approves Carbetocin Ferring for the prevention of postpartum haemorrhage in all births

13 May 2020 - Carbetocin Ferring is the first medicine approved under the new Swissmedic and Marketing Authorisation for Global Health ...

Read more →

Seattle Genetics announces the approval of Tukysa (tucatinib) in Switzerland for the treatment of patients with metastatic HER2-positive breast cancer

12 May 2020 - First approval for Tukysa outside of the U.S. ...

Read more →

Swift COVID-19 vaccine within reach, say Swiss scientists

21 April 2020 - A team of researchers at the University of Bern is hoping to be the first to ...

Read more →

Swiss deal on cystic fibrosis drugs could change price negotiations

21 April 2020 - The deal is expected to help 400 eligible cystic fibrosis patients in Switzerland. ...

Read more →

Novartis announces first European donation of hydroxychloroquine to Switzerland

3 April 2020 - Novartis has committed to making a global donation of up to 130 million doses of the anti-malarial ...

Read more →

Swiss Government expands powers to force firms to make supplies to fight COVID-19

3 April 2020 - The Swiss government on Friday boosted its powers to order companies to raise production of critical ...

Read more →

FDA’s Project Orbis may expand to Singapore and Switzerland

12 November 2019 - The US FDA may expand a pilot project that allows for simultaneous drug approval decisions from ...

Read more →

Swissmedic reviewing licence extension for the SGLT2 inhibitor Invokana (canagliflozin) in fast-track procedure

9 October 2019 - The CREDENCE renal outcomes study, which was stopped early in July 2018 owing to positive efficacy findings, ...

Read more →

Mavenclad (cladribine tablets) approved as the first short-course oral treatment for relapsing remitting multiple sclerosis in Switzerland

25 March 2019 - Approval based on extensive clinical development program capturing more than 10,000 patient years of safety data and ...

Read more →

Octapharma receives Swissmedic approval for fibryga to treat congenital and acquired fibrinogen deficiencies

26 November 2018 - Octapharma today announced that the Swiss Agency for Therapeutic Products, Swissmedic, granted marketing authorisation to its new ...

Read more →

Novartis leukaemia drug approved in Switzerland

22 October 2018 - Basel-based pharmaceutical company Novartis has received approval for its personalised cell therapy Kymriah in Switzerland. Children ...

Read more →

Swissmedic approves Ameluz in combination with daylight photodynamic therapy in Switzerland

1 October 2018 - Biofrontera announced today that Swissmedic, the Swiss national approval and supervisory authority for drugs and medical ...

Read more →

Dutch, Swiss regulators forge agreement on data exchange

14 September 2018 - The heads of the Netherland’s Medicines Evaluation Board and Swissmedic have signed a memorandum of understanding ...

Read more →

'The Swiss government must make lifesaving drugs affordable'

22 May 2018 - Swiss health NGO Public Eye has launched a campaign calling for Swiss authorities to combat the ...

Read more →